• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病筛查成本效益的下降。以日本胃癌为例。

Declining cost-effectiveness of screening for disease. The case of gastric cancer in Japan.

作者信息

Babazono A, Hillman A L

机构信息

University of Pennsylvania, USA.

出版信息

Int J Technol Assess Health Care. 1995 Spring;11(2):354-64. doi: 10.1017/s0266462300006954.

DOI:10.1017/s0266462300006954
PMID:7790176
Abstract

We examined the cost-effectiveness of screening for gastric cancer in hypothetical cohorts of asymptomatic Japanese ages 40, 50, 60, and 70, followed for 10 years. Current screening recommendations in Japan are not optimal. Although indirect x-ray is the correct method, screening for gastric cancer may not be cost-effective for Japanese under the age of 50. Policymakers worldwide should monitor the changing incidence of disease as they consider and recommend screening policies.

摘要

我们在年龄分别为40岁、50岁、60岁和70岁的无症状日本假想队列中进行了为期10年的胃癌筛查成本效益研究。日本目前的筛查建议并非最佳。虽然间接X线检查是正确的方法,但对于50岁以下的日本人来说,胃癌筛查可能不具有成本效益。全球政策制定者在考虑和推荐筛查政策时,应监测疾病发病率的变化。

相似文献

1
Declining cost-effectiveness of screening for disease. The case of gastric cancer in Japan.疾病筛查成本效益的下降。以日本胃癌为例。
Int J Technol Assess Health Care. 1995 Spring;11(2):354-64. doi: 10.1017/s0266462300006954.
2
Endoscopic screening for gastric cancer.胃癌的内镜筛查
Clin Gastroenterol Hepatol. 2006 Jun;4(6):709-16. doi: 10.1016/j.cgh.2006.03.025.
3
[Effectiveness and cost-benefit of screening for gastric cancer in Japan].[日本胃癌筛查的有效性及成本效益]
Nihon Rinsho. 2001 Apr;59 Suppl 4:533-7.
4
International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.国际成本效益分析评估了针对低危和高危人群的胃癌内镜筛查。
Gastric Cancer. 2021 Jul;24(4):878-887. doi: 10.1007/s10120-021-01162-z. Epub 2021 Feb 17.
5
Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer.基于人群的幽门螺杆菌筛查预防胃癌的临床和经济效果
Arch Intern Med. 1999 Jan 25;159(2):142-8. doi: 10.1001/archinte.159.2.142.
6
Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study.在一项胃癌病例对照研究中,利用血清胃蛋白酶原筛查胃癌的临界值评估以及血清胃蛋白酶原I、II水平和PG I/PG II比值的分布情况。
J Epidemiol. 1997 Sep;7(3):143-51. doi: 10.2188/jea.7.143.
7
Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.胃癌一级和二级预防策略的成本效益分析
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):875-85. doi: 10.1158/1055-9965.EPI-06-0758.
8
Cost-effectiveness of Helicobacter pylori screening and treatment for gastric cancer in Hong Kong: a decision analytic approach.香港幽门螺杆菌筛查与胃癌治疗的成本效益:一种决策分析方法
Hong Kong Med J. 2014 Dec;20 Suppl 7:13-5.
9
Effectiveness of gastric mass screening in Japan.日本胃癌大规模筛查的有效性。
Cancer Detect Prev. 1988;11(3-6):323-9.
10
Cost-effectiveness of lung cancer screening in Japan.日本肺癌筛查的成本效益
Cancer. 2000 Dec 1;89(11 Suppl):2489-93. doi: 10.1002/1097-0142(20001201)89:11+<2489::aid-cncr29>3.3.co;2-5.

引用本文的文献

1
Economic Evaluation of Gastric Cancer Screening Strategies: A Systematic Review.胃癌筛查策略的经济学评估:一项系统综述
J Gastrointest Cancer. 2025 Mar 25;56(1):85. doi: 10.1007/s12029-025-01202-2.
2
A Systematic Review of Cost-Effectiveness Studies on Gastric Cancer Screening.胃癌筛查成本效益研究的系统评价
Cancers (Basel). 2024 Jun 27;16(13):2353. doi: 10.3390/cancers16132353.
3
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale.
关于幽门螺杆菌感染的临床管理、筛查至治疗以及监测的共识,以在全国范围内改善胃癌防控。
Helicobacter. 2017 Jun;22(3). doi: 10.1111/hel.12368. Epub 2017 Jan 8.
4
Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010.2004 年至 2010 年新加坡胃癌内镜监测项目成本效率持续提高的经验证据。
BMC Health Serv Res. 2013 Apr 15;13:139. doi: 10.1186/1472-6963-13-139.
5
Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan.日本多巴胺激动剂治疗帕金森病的成本效益分析。
Pharmacoeconomics. 2001;19(8):875-86. doi: 10.2165/00019053-200119080-00009.